Fludarabine: Difference between revisions
From OncoWiki
Jump to navigationJump to search
m (1 revision) |
|
(No difference)
|
Latest revision as of 02:18, 7 February 2012
Drug information
Prescribing informatino (Bayer,PDF)
Indications
Indolent NHL
- 25 mg/m2 iv qd d1-5 q4w
References
Chronic Lymphocytic Leukemia
- 25 mg/m2/d iv x 5 days or 40 mg/m2/d po x 5 days
Q4w x 6-12 cycles
References
- D et al. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukemia (the LRF CLL4 trial): a randomized controlled trial. Lancet 2007; 370:230
- Rai, KR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343:1750